Detalhe da pesquisa
1.
Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer.
N Engl J Med
; 389(18): 1672-1684, 2023 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37870974
2.
Land management explains major trends in forest structure and composition over the last millennium in California's Klamath Mountains.
Proc Natl Acad Sci U S A
; 119(12): e2116264119, 2022 03 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35286202
3.
The impact of myelosuppression on quality of life of patients treated with chemotherapy.
Future Oncol
; 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38587388
4.
The impact of new and emerging agents on outcomes for febrile neutropenia: addressing clinical gaps.
Curr Opin Oncol
; 35(4): 241-247, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37222193
5.
Microstructural white matter abnormalities in Lesch-Nyhan disease.
Eur J Neurosci
; 55(1): 264-276, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34738666
6.
Chemotherapy-Induced Neutropenia and Febrile Neutropenia in the US: A Beast of Burden That Needs to Be Tamed?
Oncologist
; 27(8): 625-636, 2022 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35552754
7.
A prospective study to evaluate febrile neutropenia incidence in patients receiving pegfilgrastim on-body injector vs other choices.
Support Care Cancer
; 30(10): 7913-7922, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35732748
8.
A prospective cohort study to evaluate the incidence of febrile neutropenia in patients receiving pegfilgrastim on-body injector versus other options for prophylaxis of febrile neutropenia: breast cancer subgroup analysis.
Support Care Cancer
; 30(7): 6135-6144, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35426046
9.
Relative Dose Intensity of Chemotherapy and Survival in Patients with Advanced Stage Solid Tumor Cancer: A Systematic Review and Meta-Analysis.
Oncologist
; 26(9): e1609-e1618, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33973301
10.
Do Patients Regret Having Received Systemic Treatment for Advanced Non-Small Cell Lung Cancer: A Prospective Evaluation.
Oncologist
; 26(3): 224-230, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33098189
11.
Effect of ischemia-reperfusion on outcomes after open mesenteric bypass for chronic mesenteric ischemia.
J Vasc Surg
; 74(4): 1301-1308.e1, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33887424
12.
Prophylactic pegfilgrastim to prevent febrile neutropenia among patients receiving biweekly (Q2W) chemotherapy regimens: a systematic review of efficacy, effectiveness and safety.
BMC Cancer
; 21(1): 621, 2021 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34044798
13.
Relative dose intensity of first-line chemotherapy and overall survival in patients with advanced non-small-cell lung cancer.
Support Care Cancer
; 28(2): 925-932, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31172284
14.
Contemporary outcomes of thoracofemoral bypass.
J Vasc Surg
; 69(4): 1150-1159.e1, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30292606
15.
A Phase I Trial of the IGF-1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer.
Oncologist
; 23(7): 782-790, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29572245
16.
Tibial artery duplex ultrasound-derived peak systolic velocities may be an objective performance measure after above-knee endovascular therapy for arterial stenosis.
J Vasc Surg
; 68(2): 481-486, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29523435
17.
Intraluminal thrombus is associated with early rupture of abdominal aortic aneurysm.
J Vasc Surg
; 67(4): 1051-1058.e1, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29141786
18.
A systematic literature review of the efficacy, effectiveness, and safety of filgrastim.
Support Care Cancer
; 26(1): 7-20, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28939926
19.
Validation of Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials.
Oncologist
; 22(2): 189-198, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28188257
20.
Phase II Study of Dasatinib in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer.
Cancer Invest
; 35(1): 32-35, 2017 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27911119